Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study of Patients Receiving Dupilumab for Prurigo Nodularis

NCT05991323 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT05991323
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05991323 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study of Patients Receiving Dupilumab for Prurigo Nodularis
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
December 12, 2023
Completion date
September 8, 2026
Enrollment
110 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

prurigo nodularis